Annual report pursuant to Section 13 and 15(d)

STOCK WARRANTS (Details Narrative)

v3.24.1
STOCK WARRANTS (Details Narrative) - $ / shares
 1 Months Ended 3 Months Ended 12 Months Ended
Apr. 01, 2024
Dec. 20, 2023
Apr. 01, 2024
Apr. 01, 2024
Dec. 31, 2023
Oct. 03, 2023
Sep. 30, 2023
Jul. 27, 2023
Warrant [Member]                
Class of Warrant or Right [Line Items]                
Number of warrants expired         2,453      
Exercise price of warrants expired (in dollars per share)         $ 7,000.00      
Pre-Funded Warrants [Member]                
Class of Warrant or Right [Line Items]                
Exercise price         $ 0.0001      
Pre-Funded Warrants [Member] | Subsequent Event [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts 3,900,000   3,900,000 3,900,000        
Exercise price $ 0.0001   $ 0.0001 $ 0.0001        
Number of warrants exercised       15,043,244        
Common Warrants [Member] | Subsequent Event [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts 6,950,000   6,950,000 6,950,000        
Exercise price $ 0.33   $ 0.33 $ 0.33        
Termination date Apr. 01, 2029   Apr. 01, 2029 Apr. 01, 2029        
Common Warrants Series C [Member] | Subsequent Event [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts 34,823,928   34,823,928 34,823,928        
Termination date Apr. 01, 2026   Apr. 01, 2026 Apr. 01, 2026        
Period of trading days after FDA acceptance of NDA for warrant expiration 10 days   10 days          
Common Warrants Series D [Member] | Subsequent Event [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts 34,823,928   34,823,928 34,823,928        
Termination date Apr. 01, 2029   Apr. 01, 2029 Apr. 01, 2029        
Common Warrants Series A [Member] | Subsequent Event [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts 14,666,666   14,666,666 14,666,666        
Exercise price $ 0.33   $ 0.33 $ 0.33        
Warrants term 5 years 6 months   5 years 6 months 5 years 6 months        
Common Warrants Series A [Member] | Subsequent Event [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts 8,900,000   8,900,000 8,900,000        
Termination date Apr. 01, 2029   Apr. 01, 2029 Apr. 01, 2029        
Common Warrants Series B [Member] | Subsequent Event [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts 8,900,000   8,900,000 8,900,000        
Termination date Apr. 01, 2029   Apr. 01, 2029 Apr. 01, 2029        
Sales Agreement [Member] | Pre-Funded Warrants [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts         28,710,812 4,950,000 4,950,000 4,470,000
Exercise price         $ 0.0001   $ 0.0001 $ 0.0001
Sales Agreement [Member] | Common Warrants [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts             18,000,000 7,000,000
Exercise price             $ 0.50 $ 1.00
Warrants term             5 years 5 years
Sales Agreement [Member] | Common Warrants Series C [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts         81,081,081      
Exercise price         $ 0.555      
Warrants term         2 years      
Sales Agreement [Member] | Common Warrants Series D [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts         81,081,081      
Exercise price         $ 0.85      
Warrants term         5 years      
Sales Agreement [Member] | Common Warrants Series A [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts           9,000,000    
Exercise price           $ 0.50    
Warrants term           5 years    
Sales Agreement [Member] | Common Warrants Series B [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts           9,000,000    
Exercise price           $ 0.50    
Purchase Agreement [Member] | Pre-Funded Warrants [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts   28,710,812            
Exercise price   $ 0.0001            
Number of warrants exercised   6,509,010     6,509,010      
Purchase Agreement [Member] | Common Warrants Series C [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts   81,081,081            
Exercise price   $ 0.555            
Warrants term   2 years            
Period of trading days after FDA acceptance of NDA for warrant expiration   10 days            
Purchase Agreement [Member] | Common Warrants Series D [Member]                
Class of Warrant or Right [Line Items]                
Number of shares for common warramts   81,081,081            
Exercise price   $ 0.85            
Warrants term   5 years